Outsourced Pharma App Notes & Case Studies

1. Extractables In Single-Use Systems Used In ADC Manufacturing 9/23/2024

   To address concerns about using organic solvents in the ADC process, extractables studies were conducted on a disposable chromatography column housing and two different disposable flow paths.

2. CDMO Accelerates Contract Manufacturing With Electronic Batch Records 9/18/2024

   A prominent CDMO sought a specialized software solution to streamline and accelerate its manufacturing processes, enabling the efficient production of complex, customized products in record time.

3. Impact Of Media Selection 6/30/2025

   To highlight the importance of media selection, a study was conducted assessing the effect of three commercially available cGMP grade medias and their influence on T-cell phenotype.

4. Tackling Antimicrobial Resistance 5/14/2024

   Learn how three companies collaborated to develop a new antibiotic to address the increasing development of antimicrobial resistance (AMR) that threatens the global health landscape.

5. Simplifying CHO Cell Line Genetic Stability Testing 4/11/2024

   Here, we describe the use of whole genome sequencing to perform a comprehensive assessment of genetic stability in clonally derived CHO cell banks using the Aptegra™ CHO genetic stability assay.

6. A Smarter Workforce Strategy 8/11/2025

   Discover compliant, on-site scientific staffing that ensures continuity, reduces HR burden, avoids co-employment risks, and outperforms temporary staffing in retention, cost savings, and operational efficiency.

7. Modifying The Micro-Environment To Improve Dissolution Rate 6/11/2025

   Discover how modifying the micro-environment with targeted excipients can significantly enhance the dissolution rate of poorly soluble drugs using conventional manufacturing methods.

8. Creating Equity 7/10/2025

   Eurofins PSS provided full-time, benefit-rich staffing to replace inequitable temporary roles, creating long-term value, equity, and continuity for a major biopharma client.

9. Optimizing Upstream Process Development To Increase mAb Titers 3/28/2025

   Uncover how we were able to help a client develop an efficient upstream process for a novel monoclonal antibody (mAb), resulting in a more than 100% increase in titers.

10. Cancer Therapeutic Drug Developer Minimizes Production Losses 1/8/2024

    Follow the journey of a prominent cancer therapeutics developer who faced persistent manufacturing challenges with liquid-filled capsules, and how they overcame product and monetary losses.